Calibrate PBPK–ML frameworks for ginsenoside carriers to simulate EPR vs ligand-mediated targeting, enabling in silico screening of folate, transferrin, or peptide modifications on Rg3 or Rb1 nanoparticles to maximize tumor or brain uptake. Here, TF is linked to neoplasm.